|
GK5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.489820E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.174260E-02 |
| Normal-vs-Stage2 |
5.620200E-01 |
| Normal-vs-Stage3 |
9.168600E-01 |
| Normal-vs-Stage4 |
6.207000E-01 |
| Stage1-vs-Stage2 |
8.017200E-03 |
| Stage1-vs-Stage3 |
1.531970E-02 |
| Stage1-vs-Stage4 |
1.562340E-02 |
| Stage2-vs-Stage3 |
6.789000E-01 |
| Stage2-vs-Stage4 |
9.752600E-01 |
| Stage3-vs-Stage4 |
7.073000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.236800E-01 |
| Normal-vs-AfricanAmerican |
7.847200E-01 |
| Normal-vs-Asian |
1.801930E-02 |
| Caucasian-vs-AfricanAmerican |
6.690200E-01 |
| Caucasian-vs-Asian |
7.784500E-02 |
| AfricanAmerican-vs-Asian |
1.473160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.564300E-02 |
| Normal-vs-Female |
4.410000E-01 |
| Male-vs-Female |
7.806300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.076200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.426600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.506600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.867610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.161520E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.435700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.996460E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.376400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.303800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.130000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.033600E-04 |
| Classical-VS-Follicular |
1.393660E-02 |
| Classical-VS-Other |
9.417200E-01 |
| Classical-VS-Normal |
2.306500E-02 |
| Tall-VS-Follicular |
2.769400E-01 |
| Tall-VS-Other |
6.283900E-02 |
| Tall-VS-Normal |
1.875570E-01 |
| Follicular-VS-Other |
3.253400E-01 |
| Follicular-VS-Normal |
8.022200E-01 |
| Other-VS-Normal |
2.532000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.951800E-01 |
| Normal-vs-N1 |
4.639500E-03 |
| N0-vs-N1 |
1.397710E-02 |
|
|
